Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online March 14, 2012.
Article Versions
- Earlier version (March 8, 2012 - 05:54).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- E. J. Verspohl
- Martin C. Michel, ASSOCIATE EDITOR
- Address correspondence to:
Dr. Eugen J. Verspohl, Department of Pharmacology, Institute of Medicinal Chemistry, University of Muenster, Hittorfstr. 58-62, 48149 Muenster, Germany. E-mail: verspoh{at}uni-muenster.de
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- I. Introduction
- II. Incretin Mimetics and Incretin Analogs
- III. Dipeptidyl-Peptidase 4 Inhibitors
- IV. Sodium-Coupled Glucose Cotransporter 2 Inhibitors
- V. Pramlintide (Amyloid Deposits, Amylin)
- VI. Peroxisome Proliferator-Activated Receptor Agonists (New Glitazones and Glitazars); Glitazars Are Dual Peroxisome Proliferator-Activated Receptor Agonists
- VII. New Glinides
- VIII. Enzymes as Targets (Signaling Systems)
- IX. Physiological Compounds (Hormones)
- X. New Remedies with Respect to Late Complications of Diabetes
- XI. G-Protein-Coupled Receptors
- XII. Hypothetical New Targets (Emerging Targets) Still Lacking Therapeutic Significance
- Acknowledgments
- Authorship Contributions
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement